{
    "2021-04-30": [
        [
            {
                "time": "",
                "original_text": "西南证券维持稳健医疗买入评级：盈利能力稳定，渠道协同发力",
                "features": {
                    "keywords": [
                        "西南证券",
                        "稳健医疗",
                        "买入评级",
                        "盈利能力",
                        "渠道协同"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "405股获券商买入评级，桐昆股份目标涨幅达107.17%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "桐昆股份",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}